logo

For the Inventor, By the Inventor

Durham, NC, United States of America

Inspire Pharmaceuticals, Inc.


USPTO Granted Patents = 91



Forward Citations = 1,279

Loading Chart...
Loading Chart...

68 inventors (with patents filed for the assignee):

goldMedal Benjamin R Yerxa (49 out of 54 patents)

silverMedal Janet L Rideout (31 out of 63 patents)

bronzeMedal William Pendergast (28 out of 48 patents)

4.  Sammy Ray Shaver (22 out of 31 patents)

5.  Ward M Peterson (20 out of 21 patents)

6.  James G Douglass, Iii (19 out of 19 patents)

7.  Karla M Jacobus (18 out of 20 patents)

8.  José L Boyer (17 out of 18 patents)

9.  Paul Steven Watson (15 out of 23 patents)

10.  Robert Plourde, Jr (10 out of 13 patents)

11.  Edward G Brown (10 out of 12 patents)

12.  John W Lampe (9 out of 18 patents)

13.  Christopher S Crean (9 out of 9 patents)

14.  David J Drutz (9 out of 12 patents)

15.  David J Slade (7 out of 9 patents)


Core Competencies:
Rho Kinase Inhibitors
Purinergic Receptor Agonists
Cytoskeletal Active Compounds
Platelet Aggregation Inhibition
Neurological Diseases Treatment
Cystic Fibrosis Therapy
Dry Eye Disease Treatment
Inflammatory Diseases Management
Pharmaceutical Formulations
Sinusitis Treatment
Lacrimal System Drainage
Epithelial Tissue Diseases

91 patents:

1. 8604218 - Cytoskeletal active rho kinase inhibitor compounds, composition and use (2013-12-10),
2. 8604205 - Cytoskeletal active rho kinase inhibitor compounds, composition and use (2013-12-10),
3. 8410147 - Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds (2013-04-02),
4. 8349806 - Method of treating blepharitis (2013-01-08),
5. 8299096 - Method for treating pulmonary diseases using rho kinase inhibitor compounds (2012-10-30),
6. 8207195 - Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds (2012-06-26),
7. 8168597 - Method for treating cystic fibrosis (2012-05-01),
8. 8158796 - Process for the preparation of Rho-kinase inhibitor compounds (2012-04-17),
9. 8158776 - [object Object] (2012-04-17),
10. 8097600 - Method of increasing tear production with purinergic receptor agonists (2012-01-17),
11. 8071779 - Cytoskeletal active rho kinase inhibitor compounds, composition and use (2011-12-06),
12. 8039465 - Cytoskeletal active compounds, composition and use (2011-10-18),
13. 8008274 - P1-(2'-deoxycytidine 5′-)P4-(uridine 5′-)tetraphosphate, tetra-(alkali metal) salt, for treating sinusitis (2011-08-30),
14. D640554 - Medicine dispenser (2011-06-28),
15. 7947850 - Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones (2011-05-24),
Inspire Pharmaceuticals, Inc. is a pharmaceutical company dedicated to developing innovative therapies for ophthalmic diseases. With a focus on improving the lives of patients, Inspire Pharmaceuticals aims to provide effective treatments for conditions such as dry eye disease and cystic fibrosis-associated lung infections. Through extensive research and development, the company strives to deliver breakthrough solutions that address unmet medical needs in the field of ophthalmology.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

91 Patents

#12 in Durham, NC

#99 in North Carolina

#3,961 in US

#8,185 in the World

...
Durham, NC, United States of America

Inspire Pharmaceuticals, Inc.

Forward Citations = 1,279

68 inventors:

goldMedal Benjamin R Yerxa (49 out of 54 patents)

silverMedal Janet L Rideout (31 out of 63 patents)

bronzeMedal William Pendergast (28 out of 48 patents)

4.  Sammy Ray Shaver (22 out of 31 patents)

5.  Ward M Peterson (20 out of 21 patents)

Please report any incorrect information to support@idiyas.com
Loading…